 YAVNE, Israel, March 10, 2022 GLOBE NEWSWIRE -- MediWound Ltd. Nasdaq: MDWD, a fully integrated biopharmaceutical company focused on next-generation bio-therapeutic solutions for tissue repair and regeneration, today announced that the Company will release its financial results for the fourth quarter and year ended December 31, 2021 on Thursday, March 17 2022. 